214 related articles for article (PubMed ID: 28395743)
1. Generation of a clonal induced pluripotent stem cell (iPSC) line expressing the mutant MECP2 allele from a Rett Syndrome patient fibroblast line.
Hunihan L; Brown J; Cacace A; Fernandes A; Weston A
Stem Cell Res; 2017 Apr; 20():67-69. PubMed ID: 28395743
[TBL] [Abstract][Full Text] [Related]
2. Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease.
Cardano M; Marsoner F; Zasso J; Marcatili M; Karnavas T; Lanterna LA; Conti L
Stem Cell Res; 2016 Nov; 17(3):619-622. PubMed ID: 27934593
[TBL] [Abstract][Full Text] [Related]
3. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease.
Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L
Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594
[TBL] [Abstract][Full Text] [Related]
4. Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions.
Kele M; Day K; Rönnholm H; Schuster J; Dahl N; Falk A
Stem Cell Res; 2016 Nov; 17(3):474-478. PubMed ID: 27789397
[TBL] [Abstract][Full Text] [Related]
5. Establishment of EHMT1 mutant induced pluripotent stem cell (iPSC) line from a 11-year-old Kleefstra syndrome (KS) patient with autism and normal intellectual performance.
Varga E; Nemes C; Táncos Z; Bock I; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A
Stem Cell Res; 2016 Nov; 17(3):531-533. PubMed ID: 27789404
[TBL] [Abstract][Full Text] [Related]
6. Generation of human iPSCs from urine derived cells of a non-affected control subject.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2017 Jan; 18():33-36. PubMed ID: 28395799
[TBL] [Abstract][Full Text] [Related]
7. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
[TBL] [Abstract][Full Text] [Related]
8. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
[TBL] [Abstract][Full Text] [Related]
9. Generation of human iPSCs from urine derived cells of patient with a novel heterozygous PAI-1 mutation.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2017 Jan; 18():41-44. PubMed ID: 28395801
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia.
Marsoner F; Marcatili M; Karnavas T; Bottai D; D'Agostino A; Scarone S; Conti L
Stem Cell Res; 2016 Nov; 17(3):661-664. PubMed ID: 27934603
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.
Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002
[TBL] [Abstract][Full Text] [Related]
12. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia.
Marcatili M; Marsoner F; D'Agostino A; Karnavas T; Bottai D; Scarone S; Conti L
Stem Cell Res; 2016 Nov; 17(3):630-633. PubMed ID: 27934596
[TBL] [Abstract][Full Text] [Related]
13. Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2016 Nov; 17(3):657-660. PubMed ID: 27934602
[TBL] [Abstract][Full Text] [Related]
14. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
[TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM).
Xiong K; Zhou Y; Hyttel P; Bolund L; Freude KK; Luo Y
Stem Cell Res; 2016 Nov; 17(3):665-669. PubMed ID: 27934604
[TBL] [Abstract][Full Text] [Related]
16. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
17. Characterization of dermal fibroblast-derived iPSCs from a patient with high grade steatosis.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):568-571. PubMed ID: 27789412
[TBL] [Abstract][Full Text] [Related]
18. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
[TBL] [Abstract][Full Text] [Related]
19. Generation of Isogenic Controls for In Vitro Disease Modelling of X-Chromosomal Disorders.
Hinz L; Hoekstra SD; Watanabe K; Posthuma D; Heine VM
Stem Cell Rev Rep; 2019 Apr; 15(2):276-285. PubMed ID: 30421281
[TBL] [Abstract][Full Text] [Related]
20. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.
Chen X; Han X; Blanchi B; Guan W; Ge W; Yu YC; Sun YE
Protein Cell; 2021 Aug; 12(8):639-652. PubMed ID: 32851591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
